current user: public

anford Burnham Prebys Medical Discovery Institute
We are hiring bioinformatics experts and software developers. Join us!

Query: 3s94_A mol:protein length:619 Low-density lipoprotein receptor-related prot, from PDB0516

Results of FFAS03 search in PDB0516
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610
# Score Template Links and tools%idFirst APLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSEEAIKRTEFNKTESVQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVLFWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIINSEIYWPNGLTLDYEEQKLYWADAKLNFIHKSNLDGTNRQAVVKGSLPHPFALTLFEDILYWTDWSTHSILACNKYTGEGLREIHSDIFSPMDIHAFSQQRQPNATNPCGIDNGGCSHLCLMSPVKPFYQCACPTGVKLLENGKTCKDGATELLLLARRTDLRRISLDTPDFTDIVLQLEDIRHAIAIDYDPVEGYIYWTDDEVRAIRRSFIDGSGSQFVVTAQIAHPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGEIPKIERAALDGSDRVVLVNTSLGWPNGLALDYDEGKIYWGDAKTDKIEVMNTDGTGRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAEREVIIDQLPDLMGLKATNVHRVIGSNPCAEENGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVPLast
1 -159.0003s94_A mol:protein length:619 Low-density lipoprotein receptor-related prot  ali model  100  1APLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSEEAIKRTEFNKTESVQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVLFWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIINSEIYWPNGLTLDYEEQKLYWADAKLNFIHKSNLDGTNRQAVVKGSLPHPFALTLFEDILYWTDWSTHSILACNKYTGEGLREIHSDIFSPMDIHAFSQQRQPNATNPCGIDNGGCSHLCLMSPVKPFYQCACPTGVKLLENGKTCKDGATELLLLARRTDLRRISLDTPDFTDIVLQLEDIRHAIAIDYDPVEGYIYWTDDEVRAIRRSFIDGSGSQFVVTAQIAHPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGEIPKIERAALDGSDRVVLVNTSLGWPNGLALDYDEGKIYWGDAKTDKIEVMNTDGTGRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAEREVIIDQLPDLMGLKATNVHRVIGSNPCAEENGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVP 611
2 -141.0003s2k_A mol:protein length:629 Low-density lipoprotein receptor-related prot  ali model follow..  40  4EAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSAL-EHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVP-NVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIAD-DLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQS-GWNECASSNGHCSHLCLAVPVG-GFVCGCPAHYSLNADNRTC-SAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAIVVNPEKGYMYFTNLQESPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVARIAQLSDIHAVKELNLQRQHPCAQDNGGCSHICLVKGGTTRCSCPMHLVLLQDELSCGEP 619
3 -141.0004a0p_A mol:protein length:628 LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROT  ali model follow..  40  6EAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSAL-EHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVP-NVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIAD-DLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQS-GWNECASSNGHCSHLCLAVPVG-GFVCGCPAHYSLNADNRTC-SAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAVVVNPEKGYMYFTNLQESPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVARIAQLSDIHAVKELNLQRQHPCAQDNGGCSHICLVKGGTTRCSCPMHLVLLQDELSCGGT 621
4 -140.0003s8v_A mol:protein length:623 Low-density lipoprotein receptor-related prot  ali model follow..  40  3EAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSAL-EHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVP-NVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIAD-DLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQS-GWNECASSNGHCSHLCLAVPVG-GFVCGCPAHYSLNADNRTC-SAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAIVVNPEKGYMYFTNLQESPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVARIAQLSDIHAVKELNLQRQHPCAQDNGGCSHICLVKGGTTRCSCPMHLVLLQDELSC... 615
5 -85.3003v64_C mol:protein length:349 agrin  ali model follow..  40  1.......................................................................................................................................................................................................................................................................VNECA-EEGYCSQGCTNSEGA--FQCWCEAGYELRPDRRSCKAGPEPVLLFANRIDIRQVLPHRSE---YTLLLNNLENAIALDFHHRRELVFWSDVTLDRILRANLNGSNVEEVVSTGLESPGGLAVDWVHDKLYWTDSGTSRIEVANLDGAHRKVLLWQSLEKPRAIALHPMEGTIYWTDWGNTPRIEASSMDGSGRRIIADTHLFWPNGLTIDYAGRRMYWVDAKHHVIERANLDGSHRKAVISQGLPHPFAITVFEDSLYWTDWHTKSINSANKFTGKNQEIINKLHFPMDIHTLHPQRQPGKNRCGDNNGGCTHLCLPSGQNYTCACPTGFRK-INSHACA.. 342
6 -82.5003v65_B mol:protein length:386 Low-density lipoprotein receptor-related prot  ali model follow..  38  29........................................................................................................................................................................................................................................................HTGYRLTEDGRTCQDVNECA-EEGYCSQGCTNSEGA--FQCWCEAGYELRPDRRSCALGPEPVLLFANRIDIRQVLPHRSEYT---LLLNNLENAIALDFHHRRELVFWSDVTLDRILRANLNGSNVEEVVSTGLESPGGLAVDWVHDKLYWTDSGTSRIEVANLDGAHRKVLLWQSLEKPRAIALHPMEGTIYWTDWGNTPRIEASSMDGSGRRIIADTHLFWPNGLTIDYAGRRMYWVDAKHHVIERANLDGSHRKAVISQGLPHPFAITVFEDSLYWTDWHTKSINSANKFTGKNQEIINKLHFPMDIHTLHPQRQPGKNRCGDNNGGCTHLCLPSGQNYTCACPTGFRK-INSHACAQ. 386
7 -79.4003soq_A mol:protein length:318 Low-density lipoprotein receptor-related prot  ali model follow..  99  4APLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSEEAIKRTEFNKTESVQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVLFWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIINSEIYWPNGLTLDYEEQKLYWADAKLNFIHKSNLDGTNRQAVVKGSLPHPFALTLFEDILYWTDWSTHSILACNKYTGEGLREIHSDIFSPMDIHAFSQQRQPNATNPCGIDNGGCSHLCLMSPVKPFYQCACPTGVKLLENGKTCKDGNS.............................................................................................................................................................................................................................................................................................................. 312
8 -67.0003m0c_C mol:protein length:791 Low-density lipoprotein receptor  ali model follow..  30  315...........................................................................................................................................................................................................................CLDNNGGCSHVCNDLKIGYECLCPDG-------FQLVAQRRCEDIDECQ-DPDTCSQLCVNLEGG--YKCQCEEGFQLDPHTKACKAGSIAYLFFTNRHEVRKMTLDRSEYTSLI---PNLRNVVALDTEVASNRIYWSDLSQRMICSTQLDRSSYDTVISRDIQAPDGLAVDWIHSNIYWTDSVLGTVSVADTKGVKRKTLFRENGSKPRAIVVDPVHGFMYWTDWGTPAKIKKGGLNGVDIYSLVTENIQWPNGITLDLLSGRLYWVDSKLHSISSIDVNGGNRKTILEDELAHPFSLAVFEDKVFWTDIINEAIFSANRLTGSDVNLLENLLSPEDMVLFHNLTQPR-ERTTLSNGGCQYLCLPAPPKFTCACPDGMLLARDMRSCLT. 710
9 -65.3001npe_A mol:protein length:267 nidogen  ali model follow..  31  2.....................................................................................................................................................................................................................................................................................................................THLLFAQTGKIERLPLERNTMKKKAFLHIPAKVIIGLAFDCVDKVVYWTDISEPSIGRASLHGGEPTTIIRQDLGSPEGIALDHLGRTIFWTDSQLDRIEVAKMDGTQRRVLFDTGLVNPRGIVTDPVRGNLYWTDWNDNPKIETSHMDGTNRRILAQDNLGLPNGLTFDAFSSQLCWVDAGTHRAECLNPAQPGRRKVLEG-LQYPFAVTSYGKNLYYTDWKTNSVIAMDLAISKEMDTFHKQTRLYGITIALSQCPQG.......................................... 266
10 -31.7003s25_A mol:protein length:302 Hypothetical 7-bladed beta-propeller-like pro  ali model follow..  14  2...............................................................................................................................................LNSSYVNGNTAGNLY-------NAGLFCESDGEVFFSNTNDNRLYAMNIDGSNIHKLSNDTAMY---INADKNYVYYVRNNNQ-------------------------------------------------------------------------------KITSQTFFSYDRNSLCRIKRNGHGSTVLD-------PDPCIYASLIGNYIYYLHYDTQSLYRIRIDGEEKKKIKNHYL-----FTCNTSDRYFYYNNPKNGQLYRYDTASQSEALFYDCNCYKP----VVLDDTNVYYMDVNRDNAIVHVNINNPNPVVLTEANIEHYNVYG----SLIFYQRGGDNPALCVVKNDGTGFKELAKG---EFCNINVTSQYVYFTDFVSNKEYCTSTQNPDTIKALQ............................................................ 301
11 -30.3003wwa_A mol:protein length:298 Pizza7H protein  ali model follow..  23  4..............................................................MSNTQTVLPFTGLNTPNGVAVD--AGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLNTPNGVAVDS-AGTVYVTDHGNN-RVVKLAAGSNTQTVLPFTGLNTPNGVAVD-SAGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLNTPNGVAV-----------------------------------------------------------------------------------------------------------------------------------------SAGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLNTPNGVAVD--AGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLNTPNGVAVDS-AGTVYVTDHGNN-RVVKLAAGSNTQTVLPFTGLNTPNGVAVD-SAGTVYVTDHGNNRVVKLA................................................................................................................ 296
12 -25.3002z2p_A mol:protein length:299 VIRGINIAMYCIN B LYASE  ali model follow..  16  1....................................................................................................................................................MEFKLQELNLTNQDTGPYGITVS-DKGKVWITQHKANMISCINLDGKITEYELPNKGAKVMCLTI-DGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITE------------------------------------------------------------------------------------------------PNGDIWFTEMNGNRIGRITDDGKIREYELPNKGSYPSFITLG--DNALWFTENQNNAIGRITESGDITEFKIPTPASGPVGITKGN-DDALWFVEIIGN-KIGRITTSGEITEFKIPTPNARPHAITAG-AGIDLWFTEWGANKIGRLTSNNIIEEYPIQIKSAEPAGICFDGETIWFAMEC-DKIGKLTLIKDNME................................................................ 299
13 -25.2002z2n_A mol:protein length:299 virginiamycin B lyase  ali model follow..  16  1....................................................................................................................................................MEFKLQELNLTNQDTGPYGITVS-DKGKVWITQHKANMISCINLDGKITEYPLPTPDAKVMCLTI-DGEVWFTENAANKIGRITKKGIIKEYTLPNPDSAPYGITE------------------------------------------------------------------------------------------------PNGDIWFTEMNGNRIGRITDDGKIREYELPNKGSYPSFITLG--DNALWFTENQNNAIGRITESGDITEFKIPTPASGPVGITKGN-DDALWFVEIIGN-KIGRITTSGEITEFKIPTPNARPHAITAG-AGIDLWFTEWGANKIGRLTSNNIIEEYPIQIKSAEPHGICFDGETIWFAM-ECDKIGKLTLIKDNME................................................................ 299
14 -24.7002qc5_A mol:protein length:300 Streptogramin B lactonase  ali model follow..  15  4..................................................................................................................................................AWMNFYLEEFNLSIPDSGPYGITSS-EDGKVWFTQHKANKISSLDQSGRIKEFEVPTPDAKVMCLIV-LGDIWFTENGANKIGKLSKKGGFTEYPLPQPDSGPYGITE------------------------------------------------------------------------------------------------LNGDIWFTQLNGDRIGKLTADGTIYEYDLPNKGSYPAFITLG--DNALWFTENQNNSIGRITNTGKLEEYPLPTNAAAPVGITSGN-DGALWFVEIMGN-KIGRITTTGEISEYDIPTPNARPHAITAG-KNSEIWFTEWGANQIGRITNDNTIQEYQLQTENAEPHGITF-DGSVWFALKCKIGKLNLNE...................................................................... 300
15 -24.4001rwi_B mol:protein length:270 Serine/threonine-protein kinase pknD  ali model follow..  20  21...................................................................................................................DFRLSPSGVAVDS-AGNVYVTSEGMYGRVVKLATGSTGTTVLPFNGLYQPQGLAVD-GAGTVYVTDFNNRVVTLAAGSNN-QTVLPFDGLNYPEGLAV-----------------------------------------------------------------------------------------------------------------------------------------TQGAVYVADRGNNRVVKLAAGSKTQTVLPFTGLNDPDGVAVD--SGNVYVTDTDNNRVVKLEAESNNQVVLPFTDITAPWGIAVDE-AGTVYVTEHNTN-QVVKLLAGSTTSTVLPFTGLNTPLAVAVD-SDRTVYVADRGNDRVVKLT................................................................................................................ 261
16 -20.5002gd4_L mol:protein length:58 Coagulation factor X, Stuart factor, Stuart-P  ali model follow..  30  2.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACI.. 41
17 -20.0003kl6_B mol:protein length:57 Coagulation Factor X light chain  ali model follow..  28  2.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RARKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACI.. 43
18 -19.5004yzu_B mol:protein length:62 Coagulation factor IX  ali model follow..  26  2.........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DVTCNIKNGRCEQFCKNSANKVVCSCTEGYRLAENQKSCEP. 43
19 -19.1001kig_L mol:protein length:51 FACTOR XA  ali model follow..  37  1............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................CSLDNGGCDQFCREERSEVRCSCAHGYVLGDDSKSCV.. 37
20 -18.8002ra0_L mol:protein length:51 Coagulation factor X  ali model follow..  32  2............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................CSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACI.. 38
21 -18.4001rfn_B mol:protein length:57 PROTEIN (COAGULATION FACTOR IX)  ali model follow..  28  2...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TCNIKNGRCEQFCKNSANKVVCSCTEGYRLAENQKSCEP. 41
22 -17.5001apq_A mol:protein length:53 COMPLEMENT PROTEASE C1R  ali model follow..  33  3........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DLDECASRSKSCQHLCHNYVGGYFCSCRPGYELQEDRHSCQA. 52
23 -17.2003gcw_E mol:protein length:83 Low-density lipoprotein receptor  ali model follow..  29  33.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GFQLVAQRRCEDIDECQ-DPDTCSQLCVNLEGGYKCQCEEGFQLDPHTKACK.. 83
24 -17.1003fvz_A mol:protein length:329 Peptidyl-glycine alpha-amidating monooxygenas  ali model follow..  12  16.............................LPGQVSGVALD-SKNNLVIFHRGDHVWDGNSFDSKFVYQQ--KNLFYLPHGLSID--DGNYWVTDVALHQVFKLDPHSKEGPLLIQNHFCQPTDVAVEPSTGAVFVSDGYCNSRIVQFSPSGKFVTQW-PGQFSVPHSLALVPHLDQLCVADRENGRIQCFKTDTKEFVREIKFAISYIPGFLF-NGKPYFGDQEPVQGFVMNFSSGEI----------------------------------------IDVFKPVRKHFDMPHDIVASEDGT----------------------------------------------------VYIGDAHTNTVWKFTLTEKMEHRSV........................................................................................................................................................................................................................................ 323
25 -17.1002w2m_E mol:protein length:107 LOW-DENSITY LIPOPROTEIN RECEPTOR  ali model follow..  28  49...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PDGFQLVAQRRCEDIDECQ-DPDTCSQLCVNLEGGYKCQCEEGFQLDPHTKACK.. 101
26 -16.1003hrp_A mol:protein length:409 Uncharacterized protein  ali model follow..  3...................................................DDNKTTGATYDPNQPVTVESFMPVEGKLREKVI-VKGSNFGTDKSKVKVYFVDEAAERLSTVIGRQLPGGNRIKVIVDGKEVYEQAQNVSTISGSASKDGNDDGDLASAKFKYMWGIAAV-GNNTVLAYQRDDPRVRLISVDDNKVTTVHPGFKGGKPAVTKDKQRVYSIGWEGTHTVYVYMKASGWAPTRIGQLG-----------------------------------------------------------------------------------------STFSGKIGAVALDETEEWLYFVDSNKNFGRFNVKTQEVTLIKSLGTNPGPYLIYYF--DSNFYMSDQNLSSVYKITPDGECEWFC-EALFAQPNGMTVDE-DGNFYIVDGFKGYCLRKLDILDGYVSTVAEATFNYPYDICYD-GEGGYWIAEAWGKAIRKYAVE.............................................................................................................. 409
27 -15.8001uzj_A mol:protein length:162 FIBRILLIN-1  ali model follow..  20  1.....................................................................................................................................................................................................................................................................TDVNECLDPTTCISGNCVNTPGS--YICDCPPDFELNPTRVGCVDTRS------------------------------------------------------------------------------------------------------------------------------------------------NCYLDIRPRGDNGDTACSNEIGVGVSKASCC---CSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPITVILED---------------------------------------IDECQELPGLCQGKCINTFGSFQCRCPTGYYLNEDTRVCD.. 162
28 -15.7001q7f_A mol:protein length:286 brain tumor CG10719-PA  ali model follow..  13  2.........................................THMKSQIKRQRMIYHCKFGEFGVMEGQ------FTEPSGVAVN--QNDIIVADTNNHRIQIFDKEGRFKFQF-DSQLLYPNRVAVVRNSGDIIVTERSPTHQIQIYNQYGQFVRKFGATILQHPRGVTVD-NKGRIIVVECKVMRVIIFDQNGNVLHKFCSKHLEFPNGVVVNDK----------------------------------------------------------------------------------------------------------------------------------------QEIFISDNRAHCVKVFNYEGQYLRQI-EGITNYPIGVGINSNGEILIADNHNNFNLTIFTQDGQLISAL-KVKHAQCFDVALMD-DGSVVLASKDYRLYIYRYV........................................................................................................................................................... 279
29 -15.7002w86_A mol:protein length:147 FIBRILLIN-1  ali model follow..  22  93...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GKGYSRIKGTQCEDIDECEVFPGVCKNLCVNTRGSFKCQCPSGMTLDATGRICL.. 147
30 -15.6005ex7_A mol:protein length:286 Brain tumor protein  ali model follow..  12  2.........................................PLQDPQIKRQKMIYHCKFGEFGVMEGQ------FTEPSGVAVN--QNDIIVADTNNHRIQIFDKEGRFKFQF-DSQLLYPNRVAVVRNSGDIIVTERSPTHQIQIYNQYGQFVRKFGATILQHPRGVTVD-NKGRIIVVECKVMRVIIFDQNGNVLHKFCSKHLEFPNGVVVNDK----------------------------------------------------------------------------------------------------------------------------------------QEIFISDNRAHCVKVFNYEGQYLRQI-EGITNYPIGVGINSNGEILIADNHNNFNLTIFTQDGQLISAL-KVKHAQCFDVALMD-DGSVVLASKDYRLYIYRYV........................................................................................................................................................... 279
31 -15.4001l0q_A mol:protein length:391 Surface layer protein  ali model follow..  12  1......................................................................................STFAYIANSESDNISVIDVTSNKVTATIPVG-SNPMGAVISPDGTKVYVANAHSND----SIIDTATNNVIATVPAGSPQGVAVSPDGKQVYVTNMASSTLSVIDTTSNTVAGTVKTG-KSPLGLAL-GKKLYVTNNGDKTVSVINTVTKAVINTVSVGRS--------------------------------------------PKGIAVTPDGTK---------VYVANFDSMSISVIDTVTNSVIDTVKVEAAPSGIAVNPEGTKAYVTNVDKYFNTVSMIDTGTNKITARIPVGDPAGIAVTPDGKKVYVALSFCNTVSVIDTATNTITATMAVG-KNPYASGQFIGSIPVQPVTSGYIFLSEPVQFTDLSKDATEWK--DGSSSKKQNPTHTYSETGIYTVRLTVSNSNGTDSQISTVNVV-LKGSPTPS.......................................................................................... 391
32 -15.3003bws_A mol:protein length:433 protein Lp49  ali model follow..  15  1...MLESSGDFSLLSSPINREKNGTEIVKFSIHPYKGTVIRLGEEILPFKVLEMDKNIALVEMAIPVYKDEKEIELKLSSPGFQNSSYRIRKPEELNEKLIALDKEGITHRFISRFKTFQPKSVRFID-NTRLAIPLLEDEG----DVLDINSGQTVRLSPPEKFVETISIPEHNELWVSQMQANAVHVFDLKTLAYKATVDLTGKWSKILLY-RDLVYCSNWISEDISVIDRKTKLEIRKTDKIGL--------------------------------------------PRGLLLSKDGKEL-----------------------------------IAQFSASNQESGGGRLGIYSMDKEKLIDTIGPPGN-----------KRHIVSGNTENKIYVSDMCCSKIEVYDLKEKKVQKSIPVF-DKPNTIALSPDGKYLYVSCRGPNHPTEGYLKKGLVLGKVYVIDTTQPTGLDVSPDNRYLVISDFLDHQIRVYRRDG............................................................................................................. 426
33 -15.3001lmj_A mol:protein length:86 fibrillin 1  ali model follow..  21  34.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ESGFMMMKNCMDIDECQRDPLLCRGVCHNTEGSYRCECPPGHQLSPNISACI.. 86
34 -14.7001z6c_A mol:protein length:87 Vitamin K-dependent protein S  ali model follow..  23  1.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KDVDECSLKPSICTAVCKNIPGDFECECPEGYRYNLKSKSCE.. 43
35 -14.7003vgz_A mol:protein length:353 Uncharacterized protein YncE  ali model follow..  11  5.................................................................................HLFSSRLRGSLLLGSLLVVSS--FSTQAAEEMLRKAVGKAYEMAYSQQENALWLATSQSRKLDKGGVLDPVTLEVTQAIHNDKPFGATINNTTQTLWFGNTVNSAVTAIDATGEVKGRLVLDDRKRTEEVRPLQPRELVADDATNTVYISGIGKESVIWVV-----------------------------------------------------------------------------------DGGNIKLKTAIQNTGKMSTGLALDSEGKRLYTTNADGELIT---IDTADNKILSRKKLHFFINISLDTARQRAFITDSKAAEVLV--VDTRNGNILAKVAAPESLAVLFNPARNEAYVTHRQAGK----SVIDAKSYKVVKTFDTTHPNSLALSADGKTLYVSVKQKSTKQQEATQPDDVIRI....................................................................................................... 351
36 -14.6003qqz_A mol:protein length:255 Putative uncharacterized protein yjiK  ali model follow..  26...................................................................................................................................................................................................................................................................................................................................................TNNISSLTWSAQSNTLFSTINKPAAIVEMTTNGDLIRTIPLDFVKDLETIEYI--DNQFVISDERDYAIYVISLTPNSEVKILKPTNCGFEGLAYSRQDHTFWFFKEKNPIEVYKVNGLLSSNELHISKDLDDVSGAEFNQQKNTLLVLSHESRALQEVTLVGEVIGEMLSHNIKQAEGVAMDASGNIYIVSEPNRFYRFTPQSSH.................................................................. 255
37 -14.6003u4y_A mol:protein length:331 uncharacterized protein  ali model follow..  10  9SNFGIVVEQHLRRISFFSTDTLEILNQITLGYDFVDTAITSDCSNVVVTSDFCQTLVQIETQLEPPKVVAIQEGQSSMADVDITPDDQFAVTVTGLNHPFNMQSYSFLKNKFISTIPIYDAVGIAISPNGNGLILIDRSSANTVRRFKIDADGVLFDTGQEFTRPFNITFTPDGNFAFVANLIGNSIGILETQNPENITLLNA--NLPGTIVVSRDTVYVLTESTVDVFNFNQLSGTLSFVKSFG.............................................................................................................................................................................................................................................................................................................................................................................. 262
38 -14.4001dx5_I mol:protein length:118 THROMBOMODULIN  ali model follow..  20  66...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PEGYILDDGFICTDIDECE-NGGFCSGVCHNLPGTFECICGPDSALAQIGTDC... 118
39 -14.3003gis_X mol:protein length:121 Thrombomodulin  ali model follow..  20  66...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PEGYILDDGFICTDIDECE-NGGFCSGVCHNLPGTFECICGPDSALAGQIGTDCDS 120
40 -14.2003kya_A mol:protein length:496 Putative phosphatase  ali model follow..  3...................................................DDDNVETGAFDPSKPVAISDFTPKEGGAYQKL--IYGENFGTDVSKVKVIVINVKSTYVYCFVPSGAFSEIEITVGEGENAVTTTASTTFSYEKKMVVGTDGPEGVKCCGFSDNGRLAFDPLNKHLYICYDGHKAIQLIDLKNRMLSSPLNINNKKIEGYADEAEYMIVAIDYDGKGDES-----------------------------------------------------------------------------------PSVYIIKRNADGTFDDRSDIQLIAAYKQCNGATIHPINGELYFNSYEKGQVFRLDLVDYFKTIKNGGDPSWEFQIFIHPTGKYAYFGVINNHYFMRSDYDGYRDDVGTEARMNNPCQGVFVKEEYDFYFVDRLNF-CVRKVTPEGIVSTYAEVARFRDVSGLVYDDVKEMFYVHDQVGHTIRTISMEQEEN.......................................................................................................... 478
41 -14.1001emn_A mol:protein length:82 FIBRILLIN  ali model follow..  25  35................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ILAGNECVDTDECSVGNPCGNGTCKNVIGGFECTCEEGFEP-GPMMTCE.. 82
42 -14.1001aut_L mol:protein length:114 ACTIVATED PROTEIN C  ali model follow..  30  40...........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RSGWEGRFCQREVSFLNCSLDNGGCTHYCLEEVGWRRCSCAPGYKLGDDLLQCHP. 94
43 -14.1002dg0_A mol:protein length:333 DrP35  ali model follow..  14  54..............................................................................................................................................................................................................................................................................................................................................................RQGQLFLLDVFEGNIFKINPETKEIKRPFVSHKANPAAIKIHKDGRLFVCYLGDFKSIFAATENGDNLQDIIEDTAYCIDDMVFDS-KGGFYFTDFRPLGGVYYVSPDFRTVTPII-QNISVANGIALSTDEKVLWVTETTANRLHRIALEDDGVTIYYFTGHEGPDSCCI-DDNLYVAMYGQGRVLVFNKRGYPIGQILIPGRDEGHMLRS................................................. 282
44 -13.7001z1y_A mol:protein length:186 ookinete surface protein Pvs25  ali model follow..  16  130..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................DEKKCTKTGETACQLKCNNEVCKNVEGVYKCQCMEGFTFDKEKNVCLGP 180
45 -13.6004hw6_A mol:protein length:433 hypothetical protein, IPT/TIG domain protein  ali model follow..  4............................LDVNQDSGTPFNPKEEI---------VVEKFLPTEGRKGTRVVVYG----RNFGNDVSKVKVTIGGYPAKVINVKSKAYEGDVKVSVVGDDEAELKSGVCEAKFDYQYNYVVTTFLGKLYENNTKWDFDDCGAFDNIWRMMFDPNSNDDLYWVGQRDAFRHVDFVN-QYVDIKTTNIGQCADVNF--------------------TLNGDMVVVDDQSSDTNTGIYLFTRASGFTERLSLCNARGAKTCAVHPQNG------------------------KIYYTRYHHAMISSYDPATGTLTEEEVMMDTKGSNFHIVWHPTGDWAYIIYNGKHCIYRVDYNRETGKLA-GIFVKNEAYAGEE--EYDFYFCDRDSHTVRVLTPEGRVTTYA-------------------------GRGNSREWGYVDGELRS---QALFNHPTSIAYDMKRKCFYIGDCDNHRVRKIAPE.............................................................................................................. 432
46 -13.4004lgn_A mol:protein length:749 Cellulose-binding, family II  ali model follow..  10  1..............MATTQPYTWSNVAIGGGGFVDGIVFNEGAPGILYVRTDIGGMYRWDAANGRWIPLLDWVGWNNVVSIAAD--TNKVWAADPNDGAILRSSDQGATWQIT-MPGRGMGERLAVDPNNDNILYFGAPSGKGLWRSTDSGATWSQMTNSDIQGVVWVAFDKSSSSLGQASKTINPVFWSRDGGATWQAV-TGFIPHKGVFDPVNHVLYIATSNTGGPYDGSSGDVWKFSVTSGTWTRISPVPSTDTANDYFGYSGLTIDRQHPNTIMVATWPDTIIFRSTDGGATWTRIWDWTSYPNRSLRYVLDISADEAMAIDPFNSDRMLYGTGA-TAVNDLISPPSGAPLISALGDLGGFTHADVTAVPSTIFTSPVFTTGTSVDYAELNPSIIVRAPNDRHVAFSTDGGKNFQGSEPGGVTTGGTVAASADGSRFVWAPGDPGQPVVYAVGFGNSWAAS--QGVPANAQIRSDRVNPKTFYALSNGTFYRSTD-GGVTFQPVAAGLPSSGAVGVMFSSGLYHSTNGGSSWSAITGVSSAVNVGFGKSAPGSSYPAVFVVGTIGGVT-RSDDGGTTWVRINDDQHYIGTNGRGIVYGDIA...... 736
47 -13.1003i1c_A mol:protein length:324 Diisopropyl-fluorophosphatase  ali model follow..  13  20...................................................................................................................................................................................................................................................................................................AAGPVFDKNGDFYIVAPYVEVNGKPAGEILRIDLKTGKKTVICKPNGYGGIPIGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIAKKDRMQGCAYCAFD--EGNLWITAPAGEV-SIYCFTTDGQMIQVDTAFQAPAGIAVRHMNDQLIVAEQPTK-KLWSYDIKGPAKIEIPGTHKGGAAGMDFD-EDNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPSALHF-TKTIFVTEHENNAVWKFEWQRNGKKQYCETLKF........................................................ 311
48 -13.0003li5_A mol:protein length:314 Diisopropyl-fluorophosphatase  ali model follow..  14  1..............MEIPVIEPLFTKVTEDIPGAQGPVFDKNGDFYIVAGKPAGEILRIDLKTGKKTVICKPEVNGIPAGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIAKKDRMQGCDDCAFDY-EGNLWITAPAKFGSIYCFTTDGQ--MIQVDTAFQFPDGIAVDGRPYQLIVAETPTKKLWSYDIKGPAKGHIPGTHEGGANGMDF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPSNLHFKPQTKTIFVT---EHENNAVWKFEWQRNGKKQYCETLKFGIF........................................................................................................................................................................................................................................................................................................................... 314
49 -12.9002fpb_A mol:protein length:322 Strictosidine Synthase  ali model follow..  14  1.............SLALSSPILKEILIEAPSYAPNSFTFDSTNKGFY-TSVQDGRVMKYEGPNSGFVDFAYASP-GRTYDISYNLQNNQMYIVDCYYHLSVVGSEGGHATQLATSVDFKWLYAVTVDQRTGIVYFTDVSTLQIMDTSDKTGTKETTLLMKELHVPGGAEVSADSSFVLVAEFLSHQIVKYWLEGPKKGTAVLVKIPNPGNIKRNADGHFWV...................................................................................................................................................................................................................................................................................................................................................................................................... 244
50 -12.9002fp8_A mol:protein length:322 Strictosidine synthase  ali model follow..  13  1.............SLALSSPILKEILIEAPSYAPNSFTFDSTNKGFYFVDFAYASPYWNKAFCENSTDAEKRPLCGRTYDISYNLQNNQLYIVDCYYHLSVVGSEGGHATQLATSVDFKWLYAVTVDQRTGIVYFTDVSTLQIMDTSDKTGTKETTLLLKELHVPGGAEVSADSSFVLVAEFLSHQIVKYWLEGPKKGTAVLVKIPNPGNIKRNADGHFWV...................................................................................................................................................................................................................................................................................................................................................................................................... 244
51 -12.9001e1a_A mol:protein length:314 DIISOPROPYLFLUOROPHOSPHATASE  ali model follow..  15  1..............MEIPVIEPLFTKVTEDIPGAEGPVFDKNGDFYIVNGKPAGEILRIDLKTGKKTVICKPEVNGIPAGCQCDRDANQLFVADMR-LGLLVVQTDGTFEEIAKKDRMQGCNDCAFDY-EGNLWITAPAKFGSIYCFTTDGQ--MIQVDTAFQFPNGIAVDGRPYQLIVAETPTKKLWSYDIKGPAKIEIPGTHEGGADGMDF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPSNLHFKPQTKTIFVT---EHENNAVWKFEWQRNGKKQYCETLKFG............................................................................................................................................................................................................................................................................................................................. 312
52 -12.7001xfe_A mol:protein length:83 Low-density lipoprotein receptor  ali model follow..  40  38..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EPIKECGTNECLDNNGGCSHVCNDLKIGYECLCPDGFQLVAQRR-C... 82
53 -12.7002p4o_A mol:protein length:306 hypothetical protein  ali model follow..  11  44TIFVTNHEVGEIVSITPDGN---QQIHATVEGKVSGLAFT-SNGDLVATGWNADSIPVVSLVKSDGTVETLLTDAIFLNGITPL--DTQYLTADSYRGAIWLIDVVQPSGSIWLEHESVFPAANGLKRFGNFLYVSNTEK-MLLLRIPVTDKPGEPEIFVEQTNIDDFAFD-VEGNLYGATHIYNSVVRIAPDRSTTIIAAEQGVIGSTAVAF-CTAIYVVTNGGMFLPPPTGVVPANVVRLEVG.............................................................................................................................................................................................................................................................................................................................................................................. 299
54 -12.6003hlh_A mol:protein length:314 Diisopropyl-fluorophosphatase  ali model follow..  15  1..............MEIPVIEPLFTKVTEDIPGAEGPVFDKNGDFYIVNGKPAGEILRIDLKTGKKTVICKPEVNGIPAGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIAKKRRMQGCNDCAFDY-EGNLWITA-EKFGSIYCFTTDGQ--MIQVDTAFQFPNGIAVDGRPYQLIVAEMPTKKLWSYDIKGPAKIEIPGTHEGGADGMDF-DNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPSNLHFKPQTKTIFVT---EHENNAVWKFEWQRNGKKQYCETLKFGI............................................................................................................................................................................................................................................................................................................................ 313
55 -12.5005c2v_B mol:protein length:352 HYDRAZINE SYNTHASE BETA SUBUNIT  ali model follow..  13  1..............................................................GYIQGTHVKTDL-PGPFHITMSPDGSTLFISNQSGHSVTFVDARTQKVTGEVAVR-VQPEASAVTPDGAFLYVCNAESDS----SVVDIQRKQEIKEIKVGWPSGIKISPDGKTAYVACSGCNAIDVIDTGRMEKVRSIYTSDYGPRMVEISPDTLVAILDTVGSINRSVDFIDIASGRVVENRVIHESSN--------------------------------------LRDVVYTPDGKY--------IAVTHQTPKNWLPVCEAENGQV-----------------FTNNVTIIETKAGGKVARLPLDDLNNY------GNPYGMAMDPKGKYLYIGVRGMHRVTILDMDKVLGLVRSSTQ-EELDYLRDDL---------------------GLVRDYLVARVPTLGPSSVCLSPDGKFCYAANYFSNNVTVIRTAVD............................................................................................................ 352
56 -12.5002kl7_A mol:protein length:71 Fibulin-4  ali model follow..  26  1.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SDVNECLTIPEACEMKCINHYGGYLCPCPPGYEPDDQD-SCV.. 70
57 -12.4001fax_L mol:protein length:96 FACTOR XA  ali model follow..  26  39.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ELFTRKLCSLDNGDCDQFCHEEQASVVCSCARGYTLADNGKACIP. 83
58 -12.1004o5t_A mol:protein length:337 Diisopropyl-fluorophosphatase  ali model follow..  15  31..............................................................................................................................................................................................................................................................................................................................................FYVVASPLSEALINANSLAEAYEARSDAGEILHIDLKTGKKTVICKPEVGSPIGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIANKRCMQGCAYCAFDY-EGNLWITAPAKFGSIYCFTTDGQ--MIQVDTAFQCPAGIAVDGRPYQLIVAEQPTKKLWSYDIKGPAN-HIPGTHKGGAAGMVF-DNNLLVANWGSSHIEVFGPDGGQPKMRIR............................................................ 277
59 -12.0005chb_A mol:protein length:87 nvPizza2-S16H58  ali model follow..  26  4......................................................................MFTGLNTPSGVAVD--AGTVYVTDHGNNRVVKLAAGSNTQTVLPFTGLNTPHGVAVDS-AGTVYVTDHGNN-RVVKLAAGSNTQTVL...................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 87
60 -12.0004zcn_A mol:protein length:87 nvPizza2-S16S58  ali model follow..  19  4.................................................................................................................MFTGLNTPSGVAVDS-AGTVYVTDHGNN-RVVKLAAGSNTQTVLPFTGLNTPSGVAVD-SAGTVYVTDHGNNRVVKLAAGSNTQTVL........................................................................................................................................................................................................................................................................................................................................................................................................................... 87
61 -11.9001p0s_L mol:protein length:138 Coagulation factor X precursor  ali model follow..  30  87..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIP. 126
62 -11.8005fkq_A mol:protein length:733 ENDO-1,4-BETA-GLUCANASE/XYLOGLUCANASE, PUTATI  ali model follow..  1..............MAPSENYTWKNVRIDGGGFVPGIIFNQKEADLIYARTAIGGAYRWNSATSSWIPLL-NWGWNGVMSLATDAADPNRVYADPNNGAILRSTDRGNTWQAT-MPGRGMGERLAIDPNRNSIIYYGAEGGNGLWRSTDYGATWAKV--SSFTNGGNYAQDPNDPNDYLNKITQNAIYRSTDGGTTWSRLAGQPTGFLPHKGVYNGVLYIADGAKGDVWKFTA-SSGTWTNISPIPSSSSDLYFGYSGLTIDRKNPNTLMVASQIA----WWPDAVFFRSTNGGASWTRIWDWTSYPSRSFRYTMDITEVPWLNFGNSNPVAPEVSPKLGWMNESVEIDPHNSNRLMYGTGATIYATENLTSWDSGGQILLKPTAVLDVVSPPVGAPVYSALGDIGGFRHDDLTKVPTSMYTTPNFSSTTSIDFAELQPATMVRVGDSGGGIGVTTNAGGSWWQGQNPGVTSGGNVALAADGGAIVWAPGGSTNVYLSTTFGSTWTAISALPAGAVIEADRVNPNKFYALANGTFYVSTNKGASFSATVTAGIPAAARKFKAVYGREGDIWLAGGSSTTTYGLWRSTNSGAS................... 642
63 -11.8001nfu_B mol:protein length:195 COAGULATION FACTOR XA, LIGHT CHAIN  ali model follow..  30  82..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................KLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIP. 121
64 -11.7003u0s_A mol:protein length:337 Diisopropyl-fluorophosphatase  ali model follow..  13  58............................................................................................................................................................................................................................................................................................................................AGEILRIDLKTGKKTVICKPNGYGGSPIGCQCDRDANQLFVADMRLG-LLVVQTDGTFEEIAKKDRMQGCAYCAFD--EGNLWITAPAGEV-SIYCFTTDGQMIQVDTAFQCPAGIAVRHMNDQLIVAEQPTK-KLWSYDIKGPAKIEIPGTHKGGAAGMDFD-EDNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPANLHF-TKTIFVTEHENNAVWKFEWQRNGKKQYCETLK......................................................... 323
65 -11.6001dqb_A mol:protein length:83 THROMBOMODULIN  ali model follow..  21  1.....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................HMEPVDPCF--RANCEYQCQPNQTSYLCVCAEGFAPIPHEPHR... 42
66 -11.6001ob1_C mol:protein length:99 MAJOR MEROZOITE SURFACE PROTEIN  ali model follow..  26  45........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PNPTCNENNGGCDAKCTEEGKKITCECTKPDSYPLDGIFCS.. 93
67 -11.6002bo2_A mol:protein length:143 EGF-LIKE MODULE CONTAINING MUCIN-LIKE HORMONE  ali model follow..  12  89..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SENTCQDVDECSSGQHQCDSVCFNTVGSYSCRCRPGWKPRHGIPNNQ.. 137
68 -11.4002mgp_A mol:protein length:99 Merozoite surface protein 1  ali model follow..  21  42..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NTCVENNNPTCDINNGGCDPSCQNASKKIICTCKEPTPNYYEGVFCS.. 96
69 -11.4001cej_A mol:protein length:96 PROTEIN (MEROZOITE SURFACE PROTEIN 1)  ali model follow..  26  45........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PNPTCNENNGGCDAKCTEEGKKITCECTKPDSYPLDGIFCS.. 93
70 -11.4004o5s_A mol:protein length:337 Diisopropyl-fluorophosphatase  ali model follow..  12  84....................................................................................................................................................................................................................................................................................................................................................GSPIGCQCDRDANQLFVADMRLG-LLVVQTEGTFEEIAKKDCMQGCAYCAFD--EGNLWITAPAGGV-SIYCFTTDGQMIQVDTAFQCPAGIAVRHMNDQLIVAEQPTK-KLWSYDIKGPANIEIPGTHKGGAAGMVFD-EDNNLLVANWGSSHIEVFGPDGGQPKMRIRCPFEKPANLHF-TKTIFVTEHDNNAVWKFE....................................................................... 309
71 -11.3001b9w_A mol:protein length:95 PROTEIN (MEROZOITE SURFACE PROTEIN 1)  ali model follow..  21  45........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................PNMTCKDKNGGCAPECKMNKNEIVCKCTKEGSEPLEGVFCS.. 89
72 -11.3002mgr_A mol:protein length:99 Merozoite surface protein 1  ali model follow..  21  42..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................NTCVENNNPTCDINNGGCDPSCQNAESTIICTCKEPTP-YYEGVFCS.. 96
73 -11.3002npr_A mol:protein length:90 Merozoite surface protein 1  ali model follow..  21  46........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................SNVTCKDNNGGCAPECKMTSNKIVCKCTKEGSPLFEGVFCS.. 90
74 -11.2003tc9_A mol:protein length:430 Hypothetical hydrolase  ali model follow..  4.......................................DNDDATGDFDPNKPVVISEFSPKEGGLGTRMLLYG----ENFGSDISKIKVTIGGQDSKVVGAKAKAYDGDIKLSILNDEGEEIANTEANEKFVYQKKMLVTTFLGTMYDGNTKYDFDDCGGFGGAVWLSFDPKNHNHLYLVGEQHPTRLIDFEKEYVSTVYSGSKVRTICWTHEADSMIITNDQNNNDRPNNYILTR------------------------------------------------------------------------------------------ESGFKVITELTKGQNCNGAETHPINGELYFNSWNAGQVFRYDFTTQETTPLFTQDSGWEFHIQFHPSGNYAYIVVVNQHYILRSDYDWKTKRLT-GTFVKNPAYKGSSD-EYDFYFCDRENH-CIRILTPQGRVTTFAQEARFNHPEGIVYDEERECFFIGDRENRRIRKIGYE.............................................................................................................. 429
75 -10.9001whe_A mol:protein length:86 COAGULATION FACTOR X  ali model follow..  13  4..............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................FLEEVKQGNLERECLEEACSLEEAREVFEDAEQTDEFWSKYKDGDQCEGHPCLNQGHCKDGIGDYTCTCAEGF----EGKNCEF. 83

FFAS is supported by the NIH grant R01-GM087218-01
1 1 6 6 2 7   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Grynberg M, Erlandsen H, Godzik A. HEPN: a common domain in bacterial drug resistance and human neurodegenerative proteins. Trends Biochem Sci. 2003 May;28(5):224-6. Review.